Statement for Appropriate Clinical Use of PCSK9 Inhibitors

類似資料

• Current Diagnosis and Management of Tangier Disease
  著者:: Koseki, Masahiro, 等
  出版事項: (2021)
• Guidance for Pediatric Familial Hypercholesterolemia 2017
  著者:: Harada-Shiba, Mariko, 等
  出版事項: (2018)
• Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report
  著者:: Iitake, Chie, 等
  出版事項: (2020)
• Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
  著者:: Harada-Shiba, Mariko, 等
  出版事項: (2018)
• Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia
  著者:: Yamashita, Shizuya, 等
  出版事項: (2020)